Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ravaud

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 1998
Phase II study of interferon-alpha and all-trans retinoic acid in metastatic renal cell carcinomaB Escudier, A Ravaud, D Berton, et al.
Bulletin Du Cancer|January 1, 1992
[Neoadjuvant chemotherapy and combined conservative treatment of soft tissue sarcoma in the adult]L Cany, N B Bui, E Stöckle, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Cardiomyopathy after acute myocardial infarction after therapy with interleukin-2 and tumour infiltrating lymphocytesA Ravaud, F Lakdja, M Delaunay, et al.
Bulletin Du Cancer|May 1, 1993
[Perception of cancer by general practitioners. Development over 15 years]M B Orgerie, A Ravaud, J L Lemasson, et al.
Molecular Psychiatry|June 26, 2002
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapyL Capuron, A Ravaud, P J Neveu, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 26, 2008
[The advantages of antiangiogenics in neoadjuvant and adjuvant locally advanced and metastatic kidney cancer: two case studies]J-M Ferrière, H Wallerand, J-C Bernhard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2012
Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinomaL Albiges, F Chamming's, B Duclos, et al.
Therapie|March 1, 1987
[Study of bioavailability parameters of propranolol in cirrhotic patients after oral administration of the delayed-action form]M Blanc, P Cales, D Grasset, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2013
Phase I dose-escalation study of oral vinflunine administered once daily for 6 weeks every 8 weeks in patients with advanced/metastatic solid tumoursJ P Delord, J M Tourani, F Lefresne, et al.
Psychoneuroendocrinology|October 5, 2001
Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapyL Capuron, A Ravaud, N Gualde, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 1998
Phase II study of interferon-alpha and all-trans retinoic acid in metastatic renal cell carcinomaB Escudier, A Ravaud, D Berton, et al.
Bulletin Du Cancer|January 1, 1992
[Neoadjuvant chemotherapy and combined conservative treatment of soft tissue sarcoma in the adult]L Cany, N B Bui, E Stöckle, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Cardiomyopathy after acute myocardial infarction after therapy with interleukin-2 and tumour infiltrating lymphocytesA Ravaud, F Lakdja, M Delaunay, et al.
Bulletin Du Cancer|May 1, 1993
[Perception of cancer by general practitioners. Development over 15 years]M B Orgerie, A Ravaud, J L Lemasson, et al.
Molecular Psychiatry|June 26, 2002
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapyL Capuron, A Ravaud, P J Neveu, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 26, 2008
[The advantages of antiangiogenics in neoadjuvant and adjuvant locally advanced and metastatic kidney cancer: two case studies]J-M Ferrière, H Wallerand, J-C Bernhard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2012
Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinomaL Albiges, F Chamming's, B Duclos, et al.
Therapie|March 1, 1987
[Study of bioavailability parameters of propranolol in cirrhotic patients after oral administration of the delayed-action form]M Blanc, P Cales, D Grasset, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2013
Phase I dose-escalation study of oral vinflunine administered once daily for 6 weeks every 8 weeks in patients with advanced/metastatic solid tumoursJ P Delord, J M Tourani, F Lefresne, et al.
Psychoneuroendocrinology|October 5, 2001
Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapyL Capuron, A Ravaud, N Gualde, et al.
Pageof 11